Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Epidural Anesthesia to Facilitate Organ Blood Flow During the First Penile Transplantation in the United States: A Case Report.

Ruscic KJ, Zamora-Berridi GJ, McGovern FJ, Cetrulo C, Winograd JM, Eberlin KR, Bojovic B, Ko DS, Anderson TA.

A A Pract. 2018 May 1;10(9):232-234. doi: 10.1213/XAA.0000000000000672.

PMID:
29708917
2.

An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate Cancer.

Miyamoto DT, Lee RJ, Kalinich M, LiCausi JA, Zheng Y, Chen T, Milner JD, Emmons E, Ho U, Broderick K, Silva E, Javaid S, Kwan TT, Hong X, Dahl DM, McGovern FJ, Efstathiou JA, Smith MR, Sequist LV, Kapur R, Wu CL, Stott SL, Ting DT, Giobbie-Hurder A, Toner M, Maheswaran S, Haber DA.

Cancer Discov. 2018 Mar;8(3):288-303. doi: 10.1158/2159-8290.CD-16-1406. Epub 2018 Jan 4.

PMID:
29301747
3.

Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience.

Rodin D, Drumm M, Clayman R, Buscariollo DL, Galland-Girodet S, Eidelman A, Feldman AS, Dahl DM, McGovern FJ, Olumi AF, Niemierko A, Shipley WU, Zietman AL, Efstathiou JA.

Clin Genitourin Cancer. 2017 Aug 3. pii: S1558-7673(17)30236-7. doi: 10.1016/j.clgc.2017.07.026. [Epub ahead of print]

PMID:
28864223
4.

Patient-reported Functional Outcomes Following Open, Laparoscopic, and Robotic Assisted Radical Prostatectomy Performed by High-volume Surgeons at High-volume Hospitals.

Gershman B, Psutka SP, McGovern FJ, Dahl DM, Tabatabaei S, Gettman MT, Frank I, Carlson RE, Rangel LJ, Barry MJ, Blute ML, Karnes RJ.

Eur Urol Focus. 2016 Jun;2(2):172-179. doi: 10.1016/j.euf.2015.06.011. Epub 2015 Jul 15.

PMID:
28723533
5.

Penis Transplantation: First US Experience.

Cetrulo CL Jr, Li K, Salinas HM, Treiser MD, Schol I, Barrisford GW, McGovern FJ, Feldman AS, Grant MT, Tanrikut C, Lee JH, Ehrlichman RJ, Holzer PW, Choy GM, Liu RW, Ng ZY, Lellouch AG, Kurtz JM, Austen WG Jr, Winograd JM, Bojovic B, Eberlin KR, Rosales IA, Colvin RB, Ko DSC.

Ann Surg. 2018 May;267(5):983-988. doi: 10.1097/SLA.0000000000002241.

PMID:
28509699
6.

Long-term results of adjuvant versus early salvage postprostatectomy radiation: A large single-institutional experience.

Buscariollo DL, Drumm M, Niemierko A, Clayman RH, Galland-Girodet S, Rodin D, Feldman AS, M Dahl D, McGovern FJ, F Olumi A, Eidelman A, Shipley WU, Zietman AL, Efstathiou JA.

Pract Radiat Oncol. 2017 Mar - Apr;7(2):e125-e133. doi: 10.1016/j.prro.2016.10.010. Epub 2016 Oct 19.

PMID:
28274403
7.

Patterns of Recurrence in Upper Tract Transitional Cell Carcinoma: Imaging Surveillance.

Mao Y, Kilcoyne A, Hedgire S, Preston MA, McGovern FJ, Dahl DM, Harisinghani M.

AJR Am J Roentgenol. 2016 Jul 6:1-8. [Epub ahead of print]

PMID:
27382922
8.

Prostato-symphyseal fistula after photoselective vaporization of the prostate: case series and literature review of a rare complication.

Sanchez A, Rodríguez D, Cheng JS, McGovern FJ, Tabatabaei S.

Urology. 2015 Jan;85(1):172-7. doi: 10.1016/j.urology.2014.09.028. Epub 2014 Nov 13. Review.

PMID:
25444634
9.

Renal radiofrequency ablation with pyeloperfusion.

Eswara JR, Gervais DA, Mueller PR, Arellano RS, Cantwell CP, McGovern FJ.

Int J Urol. 2015 Jan;22(1):131-2. doi: 10.1111/iju.12625. Epub 2014 Sep 18. No abstract available.

10.

Prognostic significance of indeterminate lung nodules in renal cell carcinoma.

Xu R, Horick N, McGovern FJ, Dahl DM, Feldman AS, Blute ML, Olumi AF, Michaelson MD.

Urol Oncol. 2014 Apr;32(3):355-61. doi: 10.1016/j.urolonc.2013.09.001. Epub 2014 Jan 4.

PMID:
24397994
11.

Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.

Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA.

Eur Urol. 2013 Mar;63(3):486-92. doi: 10.1016/j.eururo.2012.08.062. Epub 2012 Sep 5.

PMID:
22959191
12.

Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.

Efstathiou JA, Spiegel DY, Shipley WU, Heney NM, Kaufman DS, Niemierko A, Coen JJ, Skowronski RY, Paly JJ, McGovern FJ, Zietman AL.

Eur Urol. 2012 Apr;61(4):705-11. doi: 10.1016/j.eururo.2011.11.010. Epub 2011 Nov 12.

PMID:
22101114
13.

A prospective study of symptom distress and return to baseline function after open versus laparoscopic radical prostatectomy.

Dahl DM, Barry MJ, McGovern FJ, Chang Y, Walker-Corkery E, McDougal WS.

J Urol. 2009 Sep;182(3):956-65. doi: 10.1016/j.juro.2009.05.044. Epub 2009 Jul 17.

PMID:
19616252
14.

Percutaneous image-guided ablation of renal tumors.

Miller JC, Gervais DA, McGovern FJ, Thrall JH, Uppot RN.

J Am Coll Radiol. 2009 Jul;6(7):527-30. doi: 10.1016/j.jacr.2009.03.004. Review. No abstract available.

PMID:
19560073
15.

Evaluation of renal masses.

Miller JC, Samir A, McGovern FJ, Thrall JH, Lee SI.

J Am Coll Radiol. 2008 Jul;5(7):857-60. doi: 10.1016/j.jacr.2008.01.022. Review. No abstract available.

PMID:
18585667
16.

Case records of the Massachusetts General Hospital. Case 17-2008. A 63-year-old man with metastatic renal-cell carcinoma.

Michaelson MD, Iliopoulos O, McDermott DF, McGovern FJ, Harisinghani MG, Oliva E.

N Engl J Med. 2008 May 29;358(22):2389-96. doi: 10.1056/NEJMcpc0802449. No abstract available.

PMID:
18509125
17.

Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.

Michaelson MD, Kaufman DS, Lee H, McGovern FJ, Kantoff PW, Fallon MA, Finkelstein JS, Smith MR.

J Clin Oncol. 2007 Mar 20;25(9):1038-42.

18.

Management of ureteroiliac artery fistula.

Eisner BH, McGovern FJ.

Semin Intervent Radiol. 2007 Mar;24(1):117-8. doi: 10.1055/s-2007-971181.

19.

Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study.

Matin SF, Ahrar K, Cadeddu JA, Gervais DA, McGovern FJ, Zagoria RJ, Uzzo RG, Haaga J, Resnick MI, Kaouk J, Gill IS.

J Urol. 2006 Nov;176(5):1973-7. Erratum in: J Urol. 2008 Jun;179(6):2490. Zagoria, Ronald A [corrected to Zagoria, Ronald J].

PMID:
17070224
20.

Renal-cell carcinoma.

Cohen HT, McGovern FJ.

N Engl J Med. 2005 Dec 8;353(23):2477-90. Review. No abstract available.

PMID:
16339096
21.

Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors.

Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR.

AJR Am J Roentgenol. 2005 Jul;185(1):72-80.

PMID:
15972401
22.

Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors.

Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR.

AJR Am J Roentgenol. 2005 Jul;185(1):64-71.

PMID:
15972400
23.

Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent.

McDougal WS, Gervais DA, McGovern FJ, Mueller PR.

J Urol. 2005 Jul;174(1):61-3.

PMID:
15947578
24.

Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma.

Han WK, Alinani A, Wu CL, Michaelson D, Loda M, McGovern FJ, Thadhani R, Bonventre JV.

J Am Soc Nephrol. 2005 Apr;16(4):1126-34. Epub 2005 Mar 2.

25.

Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition.

Smith MR, Goode M, Zietman AL, McGovern FJ, Lee H, Finkelstein JS.

J Clin Oncol. 2004 Jul 1;22(13):2546-53.

PMID:
15226323
26.

Comparison of excretory phase, helical computed tomography with intravenous urography in patients with painless haematuria.

O'Malley ME, Hahn PF, Yoder IC, Gazelle GS, McGovern FJ, Mueller PR.

Clin Radiol. 2003 Apr;58(4):294-300.

PMID:
12662950
27.

Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors.

Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR.

Radiology. 2003 Feb;226(2):417-24.

PMID:
12563135
28.

Changes in body composition during androgen deprivation therapy for prostate cancer.

Smith MR, Finkelstein JS, McGovern FJ, Zietman AL, Fallon MA, Schoenfeld DA, Kantoff PW.

J Clin Endocrinol Metab. 2002 Feb;87(2):599-603.

PMID:
11836291
29.

Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.

Smith MR, McGovern FJ, Zietman AL, Fallon MA, Hayden DL, Schoenfeld DA, Kantoff PW, Finkelstein JS.

N Engl J Med. 2001 Sep 27;345(13):948-55.

30.

Gonadotropin-releasing hormone agonist failure in a man with prostate cancer.

Smith MR, McGovern FJ.

J Urol. 2001 Jul;166(1):211. No abstract available.

PMID:
11435862
31.

Low bone mineral density in hormone-naïve men with prostate carcinoma.

Smith MR, McGovern FJ, Fallon MA, Schoenfeld D, Kantoff PW, Finkelstein JS.

Cancer. 2001 Jun 15;91(12):2238-45.

PMID:
11413511
32.

Radio-frequency ablation of renal cell carcinoma: early clinical experience.

Gervais DA, McGovern FJ, Wood BJ, Goldberg SN, McDougal WS, Mueller PR.

Radiology. 2000 Dec;217(3):665-72.

PMID:
11110926
33.

Sexuality and cancer: conversation comfort zone.

Penson RT, Gallagher J, Gioiella ME, Wallace M, Borden K, Duska LA, Talcott JA, McGovern FJ, Appleman LJ, Chabner BA, Lynch TJ Jr.

Oncologist. 2000;5(4):336-44.

34.

Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid.

Koenig F, McGovern FJ, Larne R, Enquist H, Schomacker KT, Deutsch TF.

BJU Int. 1999 Jan;83(1):129-35.

PMID:
10233465
35.

Radio frequency ablation of renal cell carcinoma via image guided needle electrodes.

McGovern FJ, Wood BJ, Goldberg SN, Mueller PR.

J Urol. 1999 Feb;161(2):599-600. No abstract available.

PMID:
9915457
37.
38.

Benign prostatic hyperplasia: US-guided transrectal urethral enlargement with radio frequency--initial results in a canine model.

Goldberg SN, Hahn PF, McGovern FJ, Fogle RM, Mueller PR, Gazelle GS.

Radiology. 1998 Aug;208(2):491-8.

PMID:
9680581
39.

Autofluorescence guided biopsy for the early diagnosis of bladder carcinoma.

Koenig F, McGovern FJ, Enquist H, Larne R, Deutsch TF, Schomacker KT.

J Urol. 1998 Jun;159(6):1871-5.

PMID:
9598478
40.

Spectroscopic measurement of diffuse reflectance for enhanced detection of bladder carcinoma.

Koenig F, Larne R, Enquist H, McGovern FJ, Schomacker KT, Kollias N, Deutsch TF.

Urology. 1998 Feb;51(2):342-5.

PMID:
9495726
41.

Fluorescence detection of bladder carcinoma.

Koenig F, McGovern FJ.

Urology. 1997 Nov;50(5):778-9. No abstract available.

PMID:
9372892
42.

The use of in bowel urology. Metabolic and nutritional complications.

Stampfer DS, McDougal WS, McGovern FJ.

Urol Clin North Am. 1997 Nov;24(4):715-22.

PMID:
9391524
43.

Intracaval extension of germ cell carcinoma: diagnosis via endovascular biopsy and a review of the literature.

Fidias P, Fan CM, McGovern FJ, Wright CD, Kaufman J, Grossbard ML.

Eur Urol. 1997;31(3):376-9. Review.

PMID:
9129935
44.

Laser induced autofluorescence diagnosis of bladder cancer.

Koenig F, McGovern FJ, Althausen AF, Deutsch TF, Schomacker KT.

J Urol. 1996 Nov;156(5):1597-601.

PMID:
8863546
45.

Ureteroarterial fistula: case report and review of the literature.

Batter SJ, McGovern FJ, Cambria RP.

Urology. 1996 Sep;48(3):481-9. Review.

PMID:
8804509
46.

Gerota's fascia flap: an alternative for aortic graft coverage.

LaMuraglia GM, McGovern FJ.

Ann Vasc Surg. 1996 Jul;10(4):405-8.

PMID:
8879399
47.

Endometriosis of the bladder detected by pelvic ultrasonography.

Whitman GJ, McGovern FJ.

J Ultrasound Med. 1994 Feb;13(2):155-7. No abstract available.

PMID:
7932963
48.

Priapism in hypogonadal men receiving gonadotropin releasing hormone.

Whalen RK, Whitcomb RW, Crowley WF Jr, McGovern FJ.

J Urol. 1991 May;145(5):1051-2.

PMID:
2016792
49.

Evaluation apprehension on psychological inventories in a prison-based setting.

McGovern FJ, Nevid JS.

J Consult Clin Psychol. 1986 Aug;54(4):576-8. No abstract available.

PMID:
3745616
50.

The New Zealand dental nurse concept: decline and fall of U.S. dentistry?

McGovern FJ.

Dent Econ. 1972 Oct;62(10):25-6. No abstract available.

PMID:
4509874

Supplemental Content

Loading ...
Support Center